Case 44 – update 2

The patient is referred to haematology.  On review you note he has widespread lymphadenopathy, splenomegaly and weight loss.  You decide to commence him on treatment.

He has no past medical history and appears fit to undergo chemotherapy.

You have requested cytogenetics analysis, and results have shown 17q deletion in 35% of cells. What does this indicate?

how does this affect you management? What would be your management plan?

About TeamHaem

Online education and discussion about all things haematological
This entry was posted in Chronic leukaemia and tagged , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s